|
chr3_+_133494275
|
3.919
|
|
TF
|
transferrin
|
|
chr17_+_41003184
|
1.993
|
NM_003734
|
AOC3
|
amine oxidase, copper containing 3 (vascular adhesion protein 1)
|
|
chr16_-_29910340
|
1.814
|
NM_001114099
NM_001114100
NM_001243332
NM_001243333
NM_012410
NM_201575
|
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2
|
|
chr12_-_103311380
|
1.671
|
NM_000277
|
PAH
|
phenylalanine hydroxylase
|
|
chr14_-_94849552
|
1.350
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
chr2_-_158300517
|
1.295
|
NM_004288
|
CYTIP
|
cytohesin 1 interacting protein
|
|
chr1_-_150738232
|
1.271
|
|
CTSS
|
cathepsin S
|
|
chr22_+_24979717
|
1.120
|
NM_013430
|
GGT1
|
gamma-glutamyltransferase 1
|
|
chr1_-_160681552
|
1.069
|
NM_001778
|
CD48
|
CD48 molecule
|
|
chr6_-_41703938
|
0.972
|
NM_001167827
|
TFEB
|
transcription factor EB
|
|
chr16_+_2588000
|
0.937
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase-1
|
|
chr16_+_2587989
|
0.928
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase-1
|
|
chr8_-_80993009
|
0.889
|
NM_001025252
|
TPD52
|
tumor protein D52
|
|
chr4_+_69962191
|
0.844
|
NM_001074
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
chr10_-_73848766
|
0.777
|
NM_001134434
NM_014767
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2
|
|
chr1_-_150738255
|
0.723
|
|
CTSS
|
cathepsin S
|
|
chr16_+_12058963
|
0.710
|
NM_001192
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
chr5_-_142783975
|
0.685
|
NM_001018076
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
chr10_-_73848530
|
0.650
|
NM_001244950
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2
|
|
chr1_+_32716839
|
0.634
|
NM_005356
|
LCK
|
lymphocyte-specific protein tyrosine kinase
|
|
chr14_-_107179043
|
0.623
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
|
chr10_+_7745325
|
0.620
|
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2
|
|
chr17_+_75315632
|
0.545
|
|
SEPT9
|
septin 9
|
|
chr10_+_81073763
|
0.544
|
|
ZMIZ1
|
zinc finger, MIZ-type containing 1
|
|
chr15_-_60919642
|
0.543
|
NM_002943
NM_134260
|
RORA
|
RAR-related orphan receptor A
|
|
chr12_-_123187842
|
0.538
|
NM_177551
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
|
chr11_+_67222817
|
0.528
|
NM_145200
|
CABP4
|
calcium binding protein 4
|
|
chr10_+_7745229
|
0.528
|
NM_002216
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2
|
|
chr13_+_113741668
|
0.527
|
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like
|
|
chr20_+_46130600
|
0.525
|
NM_001174087
NM_001174088
NM_006534
NM_181659
|
NCOA3
|
nuclear receptor coactivator 3
|
|
chr6_-_11382501
|
0.504
|
NM_001142393
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
chr1_-_150738292
|
0.493
|
NM_001199739
NM_004079
|
CTSS
|
cathepsin S
|
|
chr19_-_11688441
|
0.488
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
chr1_+_50569581
|
0.474
|
NM_001144776
|
ELAVL4
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D)
|
|
chr2_-_96956458
|
0.455
|
|
SNRNP200
|
small nuclear ribonucleoprotein 200kDa (U5)
|
|
chr10_+_7745284
|
0.454
|
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2
|
|
chr7_+_94292737
|
0.453
|
|
PEG10
|
paternally expressed 10
|
|
chrX_-_2886285
|
0.449
|
|
ARSE
|
arylsulfatase E (chondrodysplasia punctata 1)
|
|
chr1_+_207262211
|
0.407
|
NM_001017365
NM_001017366
|
C4BPB
|
complement component 4 binding protein, beta
|
|
chr10_+_7745341
|
0.399
|
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2
|
|
chr19_+_17638064
|
0.398
|
|
FAM129C
|
family with sequence similarity 129, member C
|
|
chr7_+_94292816
|
0.396
|
|
PEG10
|
paternally expressed 10
|
|
chr11_-_128894008
|
0.393
|
NM_014715
|
ARHGAP32
|
Rho GTPase activating protein 32
|
|
chr19_+_18208596
|
0.389
|
NM_015016
|
MAST3
|
microtubule associated serine/threonine kinase 3
|
|
chrX_+_128913881
|
0.388
|
NM_018990
|
SASH3
|
SAM and SH3 domain containing 3
|
|
chr19_-_11688484
|
0.386
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
chr9_+_35673852
|
0.384
|
NM_001216
|
CA9
|
carbonic anhydrase IX
|
|
chr22_-_43343046
|
0.383
|
NM_007229
|
PACSIN2
|
protein kinase C and casein kinase substrate in neurons 2
|
|
chr1_+_26856259
|
0.377
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
chr7_+_26403944
|
0.365
|
NM_001199838
|
SNX10
|
sorting nexin 10
|
|
chr2_-_89513056
|
0.361
|
|
IGKC
|
immunoglobulin kappa constant
|
|
chr1_-_93342706
|
0.356
|
NM_001252271
|
FAM69A
|
family with sequence similarity 69, member A
|
|
chrX_-_33357725
|
0.350
|
NM_000109
|
DMD
|
dystrophin
|
|
chr6_-_32920812
|
0.346
|
NM_006120
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
chr9_-_130667571
|
0.341
|
|
LOC100131355
ST6GALNAC6
|
uncharacterized LOC100131355
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
|
|
chr18_+_29171729
|
0.341
|
NM_000371
|
TTR
|
transthyretin
|
|
chr14_-_94759556
|
0.336
|
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10
|
|
chr14_+_39734475
|
0.334
|
NM_203354
|
CTAGE5
|
CTAGE family, member 5
|
|
chr22_+_40322609
|
0.331
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
chr19_-_33360641
|
0.327
|
NM_001126335
NM_001243036
NM_014270
|
SLC7A9
|
solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9
|
|
chr7_-_37025696
|
0.327
|
|
ELMO1
|
engulfment and cell motility 1
|
|
chr1_+_207262583
|
0.324
|
NM_000716
NM_001017364
NM_001017367
|
C4BPB
|
complement component 4 binding protein, beta
|
|
chr1_-_92951593
|
0.318
|
NM_001127216
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
chr22_+_36649172
|
0.317
|
|
APOL1
|
apolipoprotein L, 1
|
|
chr11_-_66675334
|
0.311
|
NM_022172
|
PC
|
pyruvate carboxylase
|
|
chr13_+_97874540
|
0.304
|
NM_144778
NM_207304
|
MBNL2
|
muscleblind-like 2 (Drosophila)
|
|
chr10_+_5238756
|
0.302
|
NM_001818
|
AKR1C4
|
aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)
|
|
chr2_-_25466795
|
0.294
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
chr1_+_36772696
|
0.289
|
NM_024676
|
SH3D21
|
SH3 domain containing 21
|
|
chr10_-_75457553
|
0.288
|
NM_001144000
|
AGAP5
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5
|
|
chr10_-_14050453
|
0.276
|
|
FRMD4A
|
FERM domain containing 4A
|
|
chr2_-_183387063
|
0.264
|
NM_005019
NM_001003683
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent
|
|
chr3_-_11623829
|
0.258
|
NM_001128220
|
VGLL4
|
vestigial like 4 (Drosophila)
|
|
chr19_-_11688508
|
0.254
|
NM_001611
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
chr2_-_166930130
|
0.250
|
NM_001165963
NM_001165964
NM_006920
|
SCN1A
|
sodium channel, voltage-gated, type I, alpha subunit
|
|
chr2_+_68592317
|
0.249
|
NM_002664
|
PLEK
|
pleckstrin
|
|
chr22_+_22550112
|
0.247
|
|
|
|
|
chr15_+_58724174
|
0.246
|
NM_000236
|
LIPC
|
lipase, hepatic
|
|
chr17_+_37895023
|
0.242
|
NM_001242442
|
GRB7
|
growth factor receptor-bound protein 7
|
|
chr17_-_49124128
|
0.240
|
NM_001251971
|
SPAG9
|
sperm associated antigen 9
|
|
chr11_+_46694514
|
0.239
|
|
ATG13
|
ATG13 autophagy related 13 homolog (S. cerevisiae)
|
|
chr8_+_9413390
|
0.237
|
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
chr16_+_2588021
|
0.234
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase-1
|
|
chrX_+_128913897
|
0.224
|
|
SASH3
|
SAM and SH3 domain containing 3
|
|
chr22_+_36649116
|
0.209
|
NM_001136540
NM_001136541
NM_003661
NM_145343
|
APOL1
|
apolipoprotein L, 1
|
|
chr3_+_63884074
|
0.207
|
NM_001177387
|
ATXN7
|
ataxin 7
|
|
chr7_-_155437056
|
0.202
|
|
|
|
|
chr17_-_56296965
|
0.198
|
NM_001165927
|
MKS1
|
Meckel syndrome, type 1
|
|
chr17_-_67311773
|
0.192
|
NM_018672
|
ABCA5
|
ATP-binding cassette, sub-family A (ABC1), member 5
|
|
chr15_+_81489218
|
0.189
|
NM_001172128
|
IL16
|
interleukin 16
|
|
chr3_+_10068123
|
0.185
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
chr19_-_4338750
|
0.184
|
NM_001013841
NM_017720
|
STAP2
|
signal transducing adaptor family member 2
|
|
chr2_+_102615456
|
0.183
|
NM_173343
|
IL1R2
|
interleukin 1 receptor, type II
|
|
chr21_-_27423423
|
0.180
|
|
|
|
|
chr12_-_7261788
|
0.179
|
NM_016546
|
C1RL
|
complement component 1, r subcomponent-like
|
|
chr19_+_45417920
|
0.175
|
NM_001645
|
APOC1
|
apolipoprotein C-I
|
|
chr1_-_153919140
|
0.174
|
NM_014856
|
DENND4B
|
DENN/MADD domain containing 4B
|
|
chr7_+_94539209
|
0.174
|
NM_001166161
NM_001166162
NM_001166163
|
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A
|
|
chr8_-_66701175
|
0.173
|
NM_002603
|
PDE7A
|
phosphodiesterase 7A
|
|
chr2_+_136288953
|
0.172
|
NM_015361
|
R3HDM1
|
R3H domain containing 1
|
|
chr5_-_131879172
|
0.172
|
NM_000879
|
IL5
|
interleukin 5 (colony-stimulating factor, eosinophil)
|
|
chr15_+_25101697
|
0.169
|
NM_022805
|
SNRPN
|
small nuclear ribonucleoprotein polypeptide N
|
|
chr3_-_178984789
|
0.165
|
NM_001163677
NM_171828
|
KCNMB3
|
potassium large conductance calcium-activated channel, subfamily M beta member 3
|
|
chr1_+_244216506
|
0.161
|
NM_006352
|
ZNF238
|
zinc finger protein 238
|
|
chr15_+_74900712
|
0.160
|
NM_003992
|
CLK3
|
CDC-like kinase 3
|
|
chr12_-_48119224
|
0.157
|
NM_001172439
NM_001172440
NM_006025
|
ENDOU
|
endonuclease, polyU-specific
|
|
chr11_+_113659924
|
0.157
|
|
LOC390251
|
SH3-domain GRB2-like 1 pseudogene
|
|
chr10_+_63808968
|
0.156
|
NM_001244638
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
chr1_+_50571963
|
0.152
|
NM_001144775
|
ELAVL4
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D)
|
|
chr16_+_2587951
|
0.151
|
NM_002613
NM_031268
|
PDPK1
|
3-phosphoinositide dependent protein kinase-1
|
|
chr5_+_139876504
|
0.148
|
|
ANKHD1
|
ankyrin repeat and KH domain containing 1
|
|
chr6_+_36210944
|
0.142
|
NM_173676
NM_001145716
|
PNPLA1
|
patatin-like phospholipase domain containing 1
|
|
chr1_-_9129666
|
0.141
|
NM_001135585
NM_003039
|
SLC2A5
|
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
|
|
chr6_-_163148798
|
0.139
|
|
PARK2
|
parkinson protein 2, E3 ubiquitin protein ligase (parkin)
|
|
chr5_+_167718485
|
0.136
|
NM_001161661
NM_001161662
NM_015238
|
WWC1
|
WW and C2 domain containing 1
|
|
chr6_+_64286348
|
0.133
|
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1
|
|
chr16_+_89679715
|
0.132
|
NM_001128141
|
DPEP1
|
dipeptidase 1 (renal)
|
|
chr3_+_141043054
|
0.130
|
NM_001080412
|
ZBTB38
|
zinc finger and BTB domain containing 38
|
|
chrX_+_78200828
|
0.130
|
NM_014499
NM_198333
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10
|
|
chr12_-_108955164
|
0.127
|
NM_014706
|
SART3
|
squamous cell carcinoma antigen recognized by T cells 3
|
|
chrX_+_47082416
|
0.123
|
NM_001170460
|
CDK16
|
cyclin-dependent kinase 16
|
|
chr14_+_71996041
|
0.122
|
NM_015556
|
SIPA1L1
|
signal-induced proliferation-associated 1 like 1
|
|
chr14_-_24423329
|
0.120
|
|
C14orf167
|
chromosome 14 open reading frame 167
|
|
chr1_+_226016428
|
0.116
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
chrX_-_110513750
|
0.115
|
NM_014289
|
CAPN6
|
calpain 6
|
|
chr2_+_74057969
|
0.107
|
|
STAMBP
|
STAM binding protein
|
|
chr12_+_120105656
|
0.106
|
NM_006253
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
chr15_-_74494780
|
0.105
|
|
STRA6
|
stimulated by retinoic acid gene 6 homolog (mouse)
|
|
chr3_+_10068097
|
0.105
|
NM_001018115
NM_033084
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
chrX_-_32430370
|
0.105
|
NM_004011
NM_004012
|
DMD
|
dystrophin
|
|
chr16_+_68279297
|
0.104
|
|
PLA2G15
|
phospholipase A2, group XV
|
|
chr17_-_38073792
|
0.102
|
NM_018530
|
GSDMB
|
gasdermin B
|
|
chr1_-_51984994
|
0.101
|
NM_001981
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
chr17_+_6659155
|
0.100
|
NM_017523
NM_199139
|
XAF1
|
XIAP associated factor 1
|
|
chr8_+_56015013
|
0.100
|
NM_052898
|
XKR4
|
XK, Kell blood group complex subunit-related family, member 4
|
|
chr21_-_34185943
|
0.096
|
NM_001162495
NM_001162496
NM_019596
|
C21orf62
|
chromosome 21 open reading frame 62
|
|
chr17_-_56406120
|
0.092
|
NM_004758
NM_024418
|
BZRAP1
|
benzodiazapine receptor (peripheral) associated protein 1
|
|
chr7_+_73245192
|
0.092
|
NM_001305
|
CLDN4
|
claudin 4
|
|
chr3_-_120068077
|
0.091
|
NM_001099678
|
LRRC58
|
leucine rich repeat containing 58
|
|
chr4_+_88571453
|
0.090
|
NM_001079911
NM_004407
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
chrX_-_154563735
|
0.090
|
NM_001289
|
CLIC2
|
chloride intracellular channel 2
|
|
chr3_-_114478117
|
0.089
|
NM_001164344
NM_001164345
|
ZBTB20
|
zinc finger and BTB domain containing 20
|
|
chr12_+_62954275
|
0.086
|
|
MON2
|
MON2 homolog (S. cerevisiae)
|
|
chr1_-_9129620
|
0.085
|
|
SLC2A5
|
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
|
|
chr6_-_128841432
|
0.085
|
NM_002844
NM_001135648
|
PTPRK
|
protein tyrosine phosphatase, receptor type, K
|
|
chr3_-_187454247
|
0.085
|
NM_001130845
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
chr19_-_39368889
|
0.085
|
NM_001195833
NM_198445
|
RINL
|
Ras and Rab interactor-like
|
|
chr2_-_25467078
|
0.083
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
chr16_-_71610948
|
0.082
|
NM_000353
|
TAT
|
tyrosine aminotransferase
|
|
chr6_-_22297729
|
0.080
|
NM_000948
|
PRL
|
prolactin
|
|
chr1_+_24840800
|
0.077
|
NM_001251980
NM_001251982
NM_001251985
|
RCAN3
|
RCAN family member 3
|
|
chr8_-_20040612
|
0.077
|
NM_001135691
NM_001142324
NM_001142325
NM_003053
|
SLC18A1
|
solute carrier family 18 (vesicular monoamine), member 1
|
|
chr1_-_153013593
|
0.074
|
NM_006945
|
SPRR2D
|
small proline-rich protein 2D
|
|
chr12_-_131002409
|
0.071
|
NM_015347
|
RIMBP2
|
RIMS binding protein 2
|
|
chr12_-_7848324
|
0.071
|
NM_020634
|
GDF3
|
growth differentiation factor 3
|
|
chr13_-_27334777
|
0.069
|
NM_005288
|
GPR12
|
G protein-coupled receptor 12
|
|
chr6_+_126240369
|
0.068
|
NM_001199622
|
NCOA7
|
nuclear receptor coactivator 7
|
|
chr8_+_136470108
|
0.068
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
|
chr19_+_46195740
|
0.067
|
NM_001163377
NM_017659
|
QPCTL
|
glutaminyl-peptide cyclotransferase-like
|
|
chr14_-_69260630
|
0.066
|
NM_001244698
NM_004926
|
ZFP36L1
|
zinc finger protein 36, C3H type-like 1
|
|
chr5_-_169724817
|
0.066
|
NM_005565
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
chr1_+_150954498
|
0.064
|
NM_003568
|
ANXA9
|
annexin A9
|
|
chr16_+_68279206
|
0.062
|
NM_012320
|
PLA2G15
|
phospholipase A2, group XV
|
|
chr16_-_29874348
|
0.061
|
NM_006319
|
CDIPT
|
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
|
|
chr8_+_9413439
|
0.061
|
NM_003747
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
chr2_-_86850959
|
0.061
|
NM_001198951
NM_001198952
NM_005667
|
RNF103
|
ring finger protein 103
|
|
chr6_+_29364331
|
0.060
|
NM_013936
|
OR12D2
|
olfactory receptor, family 12, subfamily D, member 2
|
|
chr6_+_31514627
|
0.060
|
NM_001144962
NM_001144963
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
chr17_+_55055467
|
0.059
|
NM_021626
|
SCPEP1
|
serine carboxypeptidase 1
|
|
chr12_-_108954952
|
0.059
|
|
SART3
|
squamous cell carcinoma antigen recognized by T cells 3
|
|
chr6_+_167536240
|
0.057
|
NM_031409
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
chr6_-_30128688
|
0.055
|
NM_006778
NM_052828
|
TRIM10
|
tripartite motif containing 10
|
|
chr8_+_21911062
|
0.054
|
NM_001114137
|
EPB49
|
erythrocyte membrane protein band 4.9 (dematin)
|
|
chr18_+_43405544
|
0.054
|
NM_213602
|
SIGLEC15
|
sialic acid binding Ig-like lectin 15
|
|
chr17_-_16875388
|
0.052
|
NM_012452
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
chr16_+_77224827
|
0.051
|
NM_014940
|
MON1B
|
MON1 homolog B (yeast)
|
|
chr3_+_49044494
|
0.050
|
NM_018031
|
WDR6
|
WD repeat domain 6
|
|
chr8_-_38239466
|
0.050
|
|
WHSC1L1
|
Wolf-Hirschhorn syndrome candidate 1-like 1
|
|
chr3_-_149095517
|
0.050
|
NM_014220
|
TM4SF1
|
transmembrane 4 L six family member 1
|
|
chr5_+_161275897
|
0.046
|
NM_001127646
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
chr6_+_163149001
|
0.043
|
NM_001080379
|
PACRG
|
PARK2 co-regulated
|
|
chr6_-_32160289
|
0.043
|
|
GPSM3
|
G-protein signaling modulator 3
|
|
chr1_+_204042191
|
0.042
|
NM_005686
|
SOX13
|
SRY (sex determining region Y)-box 13
|
|
chr1_+_209878135
|
0.042
|
NM_005525
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
chr19_-_4103200
|
0.041
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
chr1_+_100326765
|
0.040
|
NM_000645
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
|
chr22_-_36556781
|
0.040
|
NM_145640
|
APOL3
|
apolipoprotein L, 3
|
|
chr17_-_1090562
|
0.034
|
NM_001159746
|
ABR
|
active BCR-related gene
|
|
chr8_+_74903563
|
0.033
|
NM_001195797
NM_015364
|
LY96
|
lymphocyte antigen 96
|
|
chr17_-_72542244
|
0.032
|
NM_006678
|
CD300C
|
CD300c molecule
|
|
chrX_+_153770458
|
0.031
|
NM_001099856
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
chr11_+_11863520
|
0.030
|
|
USP47
|
ubiquitin specific peptidase 47
|
|
chr19_+_10812111
|
0.029
|
NM_031209
|
QTRT1
|
queuine tRNA-ribosyltransferase 1
|
|
chr12_-_50236868
|
0.029
|
NM_181708
|
BCDIN3D
|
BCDIN3 domain containing
|
|
chr6_-_163148800
|
0.029
|
NM_004562
NM_013987
NM_013988
|
PARK2
|
parkinson protein 2, E3 ubiquitin protein ligase (parkin)
|
|
chr19_-_17516383
|
0.028
|
NM_004335
|
BST2
|
bone marrow stromal cell antigen 2
|
|
chr7_+_141478241
|
0.028
|
NM_016944
|
TAS2R4
|
taste receptor, type 2, member 4
|
|
chr19_+_17516502
|
0.028
|
|
LOC100507535
|
uncharacterized LOC100507535
|
|
chr13_+_49794471
|
0.027
|
NM_001507
|
MLNR
|
motilin receptor
|
|
chr17_-_56606534
|
0.026
|
|
SEPT4
|
septin 4
|
